Flavonoids as Potential Therapeutic Agents for the Management of Diabetic Neuropathy
- 12 December 2020
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 26 (42) , 5468-5487
Abstract
Flavonoids are secondary metabolites that are widely distributed in plants. These phenolic compounds are classified into various subgroups based on their structures: flavones, flavonols, isoflavones, flavanones, and anthocyanins. They are known to perform various pharmacological actions like antioxidant, anti-inflammatory, anticancer, antimicrobial, antidiabetic and antiallergic, etc. Diabetes is a chronic progressive metabolic disorder that affects several biochemical pathways and leads to secondary complications such as neuropathy, retinopathy, nephropathy, and cardiomyopathy. Among them, the management of diabetic neuropathy is one of the major challenges for physicians as well as the pharmaceutical industries. Naturally occurring flavonoids are extensively used for the treatment of diabetes and its related complications due to their antioxidant properties. Moreover, flavonoids inhibit various pathways that are involved in the progression of diabetic neuropathy like the reduction of oxidative stress, decrease in glycogenolysis, increase glucose utilization, decrease in the formation of advanced glycation end products, and inhibition of the α-glucosidase enzyme. This review entails current updates on the therapeutic perspectives of flavonoids in the treatment of neuropathic pain. This manuscript explains the pathological aspects of neuropathic pain, the chemistry of flavonoids, and their application in amelioration of neuropathic pain through preclinical studies either alone or in combination with other therapeutic agents.Keywords
This publication has 168 references indexed in Scilit:
- Fisetin Inhibits Hyperglycemia-Induced Proinflammatory Cytokine Production by Epigenetic MechanismsEvidence-Based Complementary and Alternative Medicine, 2012
- Protective Role of Malvidin-3-Glucoside on Peroxynitrite-Induced Damage in Endothelial Cells by Counteracting Reactive Species Formation and Apoptotic Mitochondrial PathwayOxidative Medicine and Cellular Longevity, 2012
- Baicalein alleviates diabetic peripheral neuropathy through inhibition of oxidative–nitrosative stress and p38 MAPK activationExperimental Neurology, 2011
- Treatment patterns associated with Duloxetine and Venlafaxine use for Major Depressive DisorderBMC Psychiatry, 2011
- Challenges with current treatment of neuropathic painEuropean journal of pain, 2010
- Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature UpdateMayo Clinic Proceedings, 2010
- Drug Discovery and Natural Products: End of an Era or an Endless Frontier?Science, 2009
- Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trialsBMC Neurology, 2008
- The interactions of flavonoids within neuronal signalling pathwaysGenes & Nutrition, 2007
- Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathyLife Sciences, 2007